Curaleaf (OTCMKTS:CURLF) Stock Price Down 4.4% – What’s Next?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) was down 4.4% on Thursday . The stock traded as low as $9.53 and last traded at $9.56. 152,351 shares traded hands during mid-day trading, a decline of 49% from the average daily volume of 298,911 shares. The stock had previously closed at $10.00.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Zacks Research upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 14th. Citigroup restated a “buy” rating on shares of Curaleaf in a report on Thursday, August 6th. Three research analysts have rated the stock with a Strong Buy rating and two have given a Buy rating to the company’s stock. According to MarketBeat.com, Curaleaf presently has an average rating of “Strong Buy”.

Curaleaf Stock Performance

The company has a debt-to-equity ratio of 1.06, a current ratio of 1.52 and a quick ratio of 0.73. The company has a market cap of $2.24 billion, a PE ratio of -73.76 and a beta of 1.57. The business has a fifty day simple moving average of $8.59 and a two-hundred day simple moving average of $8.01.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of ($0.20) by $0.25. The firm had revenue of $340.10 million during the quarter, compared to analyst estimates of $332.00 million. Curaleaf had a negative return on equity of 0.88% and a negative net margin of 2.62%. Research analysts anticipate that Curaleaf Holdings, Inc. will post 0.01 earnings per share for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.